Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
ANI Pharmaceuticals, Inc. company logo
ANI Pharmaceuticals, Inc. logo

ANI Pharmaceuticals, Inc. (ANIP)

Profile

Company profile for ANI Pharmaceuticals, Inc. (ANIP)
MetricValue
Full NameANI Pharmaceuticals, Inc.
TickerNASDAQ: ANIP
ExchangeNASDAQ
SectorHealthcare
IndustrySpecialty & Generic Drug Manufacturers
CountryUnited States
IPO
IndexesNot included
Websiteanipharmaceuticals.com
Employees897

Key Metrics

ANI Pharmaceuticals, Inc. Key Details
MetricDateValue
Price$84.35
Price, 1D Change+10.58%
Market Cap$2B
-
PE Ratio51.73
Beta0.59
Revenue$614M
Revenue, 1Y Change+26.20%
EPS-$1.04
EPS, 1Y Change-210.62%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
ANI Pharmaceuticals, Inc. chart

Events

ANI Pharmaceuticals, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last Split1:6
Next SplitN/AN/A
Last Ticker ChangeBPAX
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

ANIP Estimates
MetricDateValue
EPS-$1.04
EPS Estimate$7.52
EPS Est. Change+820.67%
Revenue$614.38M
Revenue Estimate$868.67M
Revenue Est. Change+41.39%
Current Price$84.35
Price Target-$112.50
Price Tgt. Change-+33.37%

🔒 Log In To Unlock Full Data

EPS

ANIP EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
$4.52$0.94-79.14%
-$0.28-$1.04-276.91%
$7.52N/A+820.67%
$8.56N/A+921.01%
ANIP EPS reported versus estimate values chart

Revenue

ANIP revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$477.25M$486.82M+2.00%
$599.19M$614.38M+2.53%
$868.67MN/A+41.39%
$955.04MN/A+55.45%
ANIP revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

ANIP Performance
MetricDateValue
Price, 1Y+53.25%
Price, 3Y+96.16%
Market Cap, 1Y+63.05%
Market Cap, 3Y+151.82%
Revenue, 1Y+26.20%
Revenue, 3Y+184.25%
EPS, 1Y-210.62%
EPS, 3Y+69.30%

🔒 Log In To Unlock Full Data

Technical Indicators

ANIP Technical Indicators
MetricDateValue
Current Price$84.35
SMA 200$77.78
SMA 200 vs Price-7.79%
SMA 50$83.32
SMA 50 vs Price-1.22%
Beta0.59
ATR$3.41
14-Day RSI56.84
10-Day Volatility68.26%
1-Year Volatility39.20%

Dividends

ANIP Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
Dividends Paid$1.63M
Payout Ratio-8.77%

🔒 Log In To Unlock Full Data

Income & Profitability

ANIP Income & Profitability
MetricDateValue
Revenue$614.38M
EPS-$1.04
Gross Profit$296.44M
Gross Margin48.25%
Operating Profit$2.22M
Operating Margin0.36%
Net Income-$18.52M
Net Margin-3.01%
EBITDA$63.12M

🔒 Log In To Unlock Full Data

Financial Health

ANIP Financial Health
MetricDateValue
Debt To Equity1.46
Current Ratio2.72
Quick Ratio2.02
-
F-Score7
Altman Z-Score1.96

Valuations

ANIP Valuations
MetricDateValue
PE Ratio51.73
PS Ratio2.29
PB Ratio3.75
EV/EBITDA15.57
Enterprise ValueN/A-

Balance Sheet

ANIP Balance Sheet
MetricDateValue
Book Value$403.68M
Cash & Equivalents$144.86M
Total Assets$1.28B
Current Assets$527.68M
Total Liabilities$880.02M
Current Liabilities$193.68M
Total Debt$655.53M
Short Term Debt$11.21M
Accounts Payable$45.66M

Expenses

ANIP Expenses
MetricDateValue
Total Expenses$612.16M
Operating Expenses$361.95M
Cost Of Goods Sold$317.94M
SG&A$249.64M
D&A$67.73M
Interest Expense$0.00
Income Tax-$3.69M

Cash Flow

ANIP Cash Flow
MetricDateValue
CFO$64.02M
CFI-$404.72M
CFF$264.95M
Capex$16.95M
Free Cash Flow$47.06M

Recent analyst updates

ANIP Recent analyst updates
MetricDateValue
Barclays
Guggenheim→
Truist Securities→
JP Morgan→
HC Wainwright & Co.→
Guggenheim→
Truist Securities→
HC Wainwright & Co.→
HC Wainwright & Co.
Guggenheim→

Analyst sentiment

Sentiment over the past month
ANIP analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
ANIP institutional ownership distribution chart

Screeners with ANIP

Data Sources & References

  1. ANIP Official Website www.anipharmaceuticals.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1023024/000102302425000108/0001023024-25-000108-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1023024/000102302425000015/0001023024-25-000015-index.htm
  4. ANIP Profile on Yahoo Finance finance.yahoo.com/quote/ANIP
  5. ANIP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/anip

FAQ

  • What is the ticker symbol for ANI Pharmaceuticals, Inc.?

    The ticker symbol for ANI Pharmaceuticals, Inc. is NASDAQ:ANIP

  • Does ANI Pharmaceuticals, Inc. pay dividends?

    No, ANI Pharmaceuticals, Inc. does not pay dividends

  • What sector is ANI Pharmaceuticals, Inc. in?

    ANI Pharmaceuticals, Inc. is in the Healthcare sector

  • What industry is ANI Pharmaceuticals, Inc. in?

    ANI Pharmaceuticals, Inc. is in the Specialty & Generic Drug Manufacturers industry

  • What country is ANI Pharmaceuticals, Inc. based in?

    ANI Pharmaceuticals, Inc. is headquartered in United States

  • When did ANI Pharmaceuticals, Inc. go public?

    ANI Pharmaceuticals, Inc. initial public offering (IPO) was on May 5, 2000

  • Is ANI Pharmaceuticals, Inc. in the S&P 500?

    No, ANI Pharmaceuticals, Inc. is not included in the S&P 500 index

  • Is ANI Pharmaceuticals, Inc. in the NASDAQ 100?

    No, ANI Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

  • Is ANI Pharmaceuticals, Inc. in the Dow Jones?

    No, ANI Pharmaceuticals, Inc. is not included in the Dow Jones index

  • When was ANI Pharmaceuticals, Inc. last earnings report?

    ANI Pharmaceuticals, Inc.'s most recent earnings report was on November 7, 2025

  • When does ANI Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for ANI Pharmaceuticals, Inc. is February 27, 2026